BioSpace News Archive

Drug Development

Post-Hoc Analysis of Phase 3 Study Examines Effect of Early Intervention with Edaravone on Survival and Disease Progression Milestone Events in ALS Patients

Mitsubishi Tanabe Pharma America, Inc. announced a post-hoc analysis of its Phase 3 edaravone study reviewing the results of intravenous edaravone treatment on disease progression milestones and events among people with amyotrophic lateral sclerosis.

March 18, 2021
·
5 min read
Business

Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board

A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care

March 18, 2021
·
10 min read
Pharm Country

National Kidney Foundation Releases Commentary on Transplant Practices

Today, the National Kidney Foundation (NKF) unveiled a review by its Kidney Disease Outcomes Quality Initiative (KDOQI) of the global Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline

March 18, 2021
·
4 min read
Biotech Bay

OpenEye Scientific Incorporates Mcule Compound Library in Orion™ Platform to Accelerate Screening of Molecules

OpenEye Scientific and Mcule – a leading online marketplace for drug discovery – today announced that OpenEye’s Orion™ molecular design platform now can greatly enhance the ability to search and screen molecules through Mcule’s purchasable compound library.

March 18, 2021
·
3 min read
Genetown

Center for Information and Study on Clinical Research Participation (CISCRP) Announces Second Annual AWARE for All 2021 Virtual Event Series

Center for Information and Study on Clinical Research Participation (CISCRP) Announces Second Annual AWARE for All 2021 Virtual Event Series The nonprofit organization aims to boost awareness and interest around clinical trial research through FREE interactive, educational events

March 18, 2021
·
4 min read
Genetown

BOA™ Biomedical’s GARNET™ therapeutic product begins First in Human clinical trial

BOA Biomedical, a Miraki™ Innovation company, focused on rapidly diagnosing and treating some of the world’s deadliest infectious diseases has announced that the company will begin its First in Human clinical trial for GARNET.

March 18, 2021
·
4 min read
Deals

Gain Therapeutics Announces Pricing of Initial Public Offering of Common Stock

Gain Therapeutics, Inc. (“Gain”) today announced the pricing of its initial public offering of 3,636,364 shares of its common stock at a price of $11.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on March 18, 2021 under the symbol “GANX.”

March 18, 2021
·
2 min read
Business

RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Financials : Full year 2020 net revenues of approximately $64 million , with gross profit of approximately $27.5 million Solid cash balance of approximately $100 million as of March 4, 2021 Planned commercial operational breakeven by the end of 2021

March 18, 2021
·
22 min read
FDA

Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval of the TheraSphere™ Y-90 Glass Microspheres, developed for the treatment of patients with hepatocellular carcinoma

March 18, 2021
·
7 min read
Business

LianBio Announces Appointment of Yi Larson as Chief Financial Officer

LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, today announced the appointment of Yi Larson as Chief Financial Officer, effective May 1, 2021. Ms. Larson will be based in the Company’s Shanghai headquarters.

March 18, 2021
·
2 min read